3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
10
Nasopharyngeal Carcinoma
6
Prostatic Neoplasms
5
Oropharyngeal Neoplasms
4
Laryngeal Neoplasms
3
Carcinoma
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Rectal Neoplasms
2
Mouth Neoplasms
2
Mesothelioma
2
Hypopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Astrocytoma
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Sarcoma
1
Salivary Gland Neoplasms
1
PSA Level Greater Than Two
1
Oligodendroglioma
1
Mesothelioma, Malignant
1
Meningioma
1
Lymphoma, Follicular
1
Lymphoid Interstitial Pneumonia
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
HIV Infections
1
Glioma
1
Interventions
selpercatinib
1
fludarabine
1
aldesleukin
1
Nivolumab
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Carcinoma, Anaplastic
×
Radiotherapy, Intensity-Modulated
×
30 days
×
Clear all
No trials found.